Related Experiment Video
Updated: Feb 24, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Multidisciplinary Heart Failure Clinics Are Associated With Lower Heart Failure Hospitalization and Mortality:
Sumeet Gandhi1, Wassim Mosleh2, Umesh C Sharma2
1McMaster University, Hamilton Health Sciences, Population Health Research Institute, Hamilton, Ontario, Canada.
Insights
Heart failure clinics (HFCs) significantly reduce heart failure hospitalizations and all-cause mortality. These benefits are most pronounced in patients with recent hospitalizations and those receiving frequent follow-up care.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- Heart failure clinics (HFCs) are crucial for managing heart failure (HF) in community settings.
- Effective HF management strategies are essential to reduce patient morbidity and mortality.
Purpose of the Study:
- To systematically evaluate the effectiveness of heart failure clinics (HFCs) in improving patient outcomes.
- To determine the impact of HFCs on heart failure hospitalizations and all-cause mortality.
Main Methods:
- A systematic literature search was performed across PubMed, EMBASE, and Cochrane databases (1990-2017).
- A meta-analysis included 16 randomized controlled trials involving 3999 patients.
- Outcomes assessed included HF hospitalization, all-cause mortality, and all-cause hospitalization.
Main Results:
- Heart failure clinics (HFCs) significantly reduced the composite endpoint of HF hospitalization and all-cause mortality (OR, 0.58; P=0.0003).
- Benefits were observed in specific subgroups, including patients with recent HF hospitalizations (OR, 0.51; P=0.0001) and those with longer follow-up (≥3 months) (OR, 0.51; P=0.0009).
- HFCs led to lower HF hospitalization rates (OR, 0.68; P=0.003) and reduced all-cause mortality (OR, 0.71; P=0.006).
Conclusions:
- Heart failure clinics (HFCs) demonstrate a clear benefit in reducing heart failure hospitalizations and all-cause mortality.
- The positive impact of HFCs is particularly significant for patients with recent acute events and those engaged in consistent follow-up care.
- These findings underscore the value of specialized HFCs in comprehensive community-based heart failure management.
Background:
Heart failure (HF) clinics (HFCs) are an integral aspect of the strategy for community HF care.
Methods:
A systematic search was conducted to retrieve studies. We searched for candidate articles in the PubMed, EMBASE, and Cochrane databases from 1990 to January 2017.
Results:
We included 16 randomized controlled trials in the meta-analysis with 3999 patients. The HFC group had a lower incidence of the primary composite end point of HF hospitalization and all-cause mortality (odds ratio [OR], 0.58; P = 0.0003). The benefit was maintained when stratified according to non-nurse led HFCs (OR, 0.52; P = 0.003), clinics that followed-up patients ≥ 3 months (OR, 0.51; P = 0.0009), patients with mean ejection fraction ≤ 30% (OR, 0.39; P = 0.02), and ejection fraction > 30% (OR, 0.72; P = 0.02), and patients with recent hospitalization for HF (OR, 0.51; P = 0.0001). There was no benefit in patients who were seen in HFCs with limited follow-up ≤ 3 months (OR, 0.91; P = 0.69), patients with stable HF without recent hospitalization (OR, 0.95; P = 0.70), and studies published after 2008 (OR, 0.89; P = 0.31). Patients in the HFC group had lower HF hospitalization rates (OR, 0.68; P = 0.003), however, no significant difference in all-cause hospitalization (OR, 1.04; P = 0.33). There was lower all-cause mortality in the HFC group (OR, 0.71; P = 0.006).
Conclusions:
The results of our analysis show a benefit of HFC to reduce HF hospitalization, and all-cause mortality. This was a cumulative benefit of all randomized clinical trials that assessed the benefit of HFC, with additional analysis showing a greater benefit among patients with recent emergency room visit or hospitalization, and patients seen frequently in follow-up ≥ 3 months.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Pathophysiology of Heart Failure
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care
Heart Failure III: Clinical Manifestations
